JP2009524686A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009524686A5 JP2009524686A5 JP2008552535A JP2008552535A JP2009524686A5 JP 2009524686 A5 JP2009524686 A5 JP 2009524686A5 JP 2008552535 A JP2008552535 A JP 2008552535A JP 2008552535 A JP2008552535 A JP 2008552535A JP 2009524686 A5 JP2009524686 A5 JP 2009524686A5
- Authority
- JP
- Japan
- Prior art keywords
- carbon atoms
- compound
- alkyl
- ring
- hydroxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 125000004432 carbon atom Chemical group C* 0.000 claims 32
- 150000001875 compounds Chemical class 0.000 claims 18
- 125000000217 alkyl group Chemical group 0.000 claims 16
- -1 perfluoromethoxy Phenyl Chemical group 0.000 claims 13
- 125000003545 alkoxy group Chemical group 0.000 claims 12
- 125000005843 halogen group Chemical group 0.000 claims 12
- 239000000203 mixture Substances 0.000 claims 9
- 125000001072 heteroaryl group Chemical group 0.000 claims 8
- 229910052739 hydrogen Inorganic materials 0.000 claims 8
- 239000001257 hydrogen Substances 0.000 claims 8
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims 8
- 150000003839 salts Chemical class 0.000 claims 8
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 8
- 206010012601 diabetes mellitus Diseases 0.000 claims 7
- 239000008194 pharmaceutical composition Substances 0.000 claims 6
- 201000001320 Atherosclerosis Diseases 0.000 claims 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 4
- 208000004930 Fatty Liver Diseases 0.000 claims 4
- 206010019708 Hepatic steatosis Diseases 0.000 claims 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 4
- 208000031226 Hyperlipidaemia Diseases 0.000 claims 4
- 208000031773 Insulin resistance syndrome Diseases 0.000 claims 4
- 208000008589 Obesity Diseases 0.000 claims 4
- 229910052799 carbon Inorganic materials 0.000 claims 4
- 125000000753 cycloalkyl group Chemical group 0.000 claims 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 4
- 208000010706 fatty liver disease Diseases 0.000 claims 4
- 125000005842 heteroatom Chemical group 0.000 claims 4
- 150000002431 hydrogen Chemical class 0.000 claims 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 4
- 229910052757 nitrogen Inorganic materials 0.000 claims 4
- 235000020824 obesity Nutrition 0.000 claims 4
- 229910052760 oxygen Inorganic materials 0.000 claims 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 4
- 231100000240 steatosis hepatitis Toxicity 0.000 claims 4
- 229910052717 sulfur Inorganic materials 0.000 claims 4
- 206010003210 Arteriosclerosis Diseases 0.000 claims 3
- 208000011775 arteriosclerosis disease Diseases 0.000 claims 3
- 201000010065 polycystic ovary syndrome Diseases 0.000 claims 3
- 206010006895 Cachexia Diseases 0.000 claims 2
- 208000002177 Cataract Diseases 0.000 claims 2
- 208000003790 Foot Ulcer Diseases 0.000 claims 2
- 206010020772 Hypertension Diseases 0.000 claims 2
- 208000017442 Retinal disease Diseases 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 208000017169 kidney disease Diseases 0.000 claims 2
- 201000001119 neuropathy Diseases 0.000 claims 2
- 230000007823 neuropathy Effects 0.000 claims 2
- 208000033808 peripheral neuropathy Diseases 0.000 claims 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims 2
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 claims 1
- 239000013543 active substance Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000006186 oral dosage form Substances 0.000 claims 1
- 208000024891 symptom Diseases 0.000 claims 1
- RDOXTESZEPMUJZ-UHFFFAOYSA-N COc1ccccc1 Chemical compound COc1ccccc1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 1
- 0 C[C@@](*)OC(N)=O Chemical compound C[C@@](*)OC(N)=O 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US76206606P | 2006-01-25 | 2006-01-25 | |
| PCT/US2007/060830 WO2007087504A2 (en) | 2006-01-25 | 2007-01-22 | Compounds for the treatment of metabolic disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009524686A JP2009524686A (ja) | 2009-07-02 |
| JP2009524686A5 true JP2009524686A5 (enExample) | 2011-01-20 |
Family
ID=38309904
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008552535A Pending JP2009524686A (ja) | 2006-01-25 | 2007-01-22 | 代謝障害を処置するための化合物 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7915429B2 (enExample) |
| EP (1) | EP1976510A4 (enExample) |
| JP (1) | JP2009524686A (enExample) |
| KR (1) | KR20080089453A (enExample) |
| CN (1) | CN101374414A (enExample) |
| AU (1) | AU2007208125B2 (enExample) |
| CA (1) | CA2637373A1 (enExample) |
| IL (1) | IL192851A0 (enExample) |
| NZ (1) | NZ569728A (enExample) |
| WO (1) | WO2007087504A2 (enExample) |
| ZA (1) | ZA200805595B (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA05008600A (es) * | 2003-02-13 | 2005-11-04 | Wellstat Therapeutics Corp | Compuestos para el tratamiento de desordenes metabolicos. |
| US7442796B2 (en) * | 2003-04-30 | 2008-10-28 | Wellstat Therapeutics Corporation | Compounds for the treatment of metabolic disorders |
| EP1978948A4 (en) * | 2006-02-02 | 2010-06-16 | Wellstat Therapeutics Corp | COMPOUNDS FOR THE TREATMENT OF METABOLISM DISORDER |
| WO2009091732A1 (en) * | 2008-01-15 | 2009-07-23 | Wellstat Therapeutics Corporation | Compounds for the treatment of metabolic disorders |
| FR2976943B1 (fr) | 2011-06-23 | 2013-07-12 | Metabolys | Derives de piperazine, leurs procedes de preparation et leurs utilisations dans le traitement de l'insulinoresistance |
Family Cites Families (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1561350A (en) | 1976-11-05 | 1980-02-20 | May & Baker Ltd | Benzamide derivatives |
| AU576457B2 (en) | 1984-02-14 | 1988-08-25 | Hirai, Hidefumi | Process for preparing p-substituted phenol derivatives |
| DE3884825D1 (de) | 1987-02-16 | 1993-11-18 | Konishiroku Photo Ind | Entwickler für lichtempfindliche lithographische Druckplatte, gemeinschaftlich verarbeitungsfähig für den Negativ-Typ und den Positiv-Typ und Entwicklerzusammensetzung für lichtempfindliches Material. |
| JPH064544B2 (ja) | 1987-06-19 | 1994-01-19 | 高砂香料工業株式会社 | 光学活性アルコ−ルの製造方法 |
| JPH0770025B2 (ja) | 1987-09-16 | 1995-07-31 | 富士通株式会社 | 薄膜磁気ヘッドの製造方法 |
| US4923501A (en) | 1987-11-04 | 1990-05-08 | Kumiai Chemical Industry Co., Ltd. | Pyrimidine derivatives, processes for their production, and herbicidal method and compositions |
| JPH04154773A (ja) | 1990-10-15 | 1992-05-27 | Green Cross Corp:The | チアゾール誘導体 |
| JPH04282345A (ja) | 1991-03-11 | 1992-10-07 | Mitsubishi Petrochem Co Ltd | 光学活性化合物 |
| WO1994005153A1 (en) | 1992-09-09 | 1994-03-17 | E.I. Du Pont De Nemours And Company | Herbicidal benzene compounds |
| US5484926A (en) | 1993-10-07 | 1996-01-16 | Agouron Pharmaceuticals, Inc. | HIV protease inhibitors |
| JPH06293700A (ja) | 1993-04-08 | 1994-10-21 | Nippon Soda Co Ltd | ６−クロロサリチル酸の製造法 |
| GB9315595D0 (en) | 1993-07-28 | 1993-09-08 | Res Inst Medicine Chem | New compounds |
| JPH07206658A (ja) | 1994-01-12 | 1995-08-08 | Shiseido Co Ltd | 尋常性座瘡治療剤 |
| JPH08119959A (ja) | 1994-10-20 | 1996-05-14 | Oyo Seikagaku Kenkyusho | キサントン誘導体及びこれを有効成分とするモノアミン酸化酵素阻害剤 |
| US5728718A (en) | 1994-12-20 | 1998-03-17 | The United States Of America As Represented By The Department Of Health And Human Services | 2,5-diamino-3,4-disubstituted-1,6-diphenylhexane isosteres comprising benzamide, sulfonamide and anthranilamide subunits and methods of using same |
| FR2730731B1 (fr) | 1995-02-20 | 1997-04-04 | Rhone Poulenc Chimie | Procede de carboxylation d'un ether aromatique |
| WO1996028423A1 (en) | 1995-03-15 | 1996-09-19 | Sankyo Company, Limited | Dipeptide compounds having ahpba structure |
| US5519133A (en) | 1995-06-02 | 1996-05-21 | American Cyanamid Co. | 3-(3-aryloxyphenyl)-1-(substituted methyl)-s-triazine-2,4,6-oxo or thiotrione herbicidal agents |
| US6194406B1 (en) | 1995-12-20 | 2001-02-27 | Aventis Pharmaceuticals Inc. | Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic disease |
| US6423704B2 (en) | 1995-12-20 | 2002-07-23 | Aventis Pharmaceuticals Inc. | Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic diseases |
| AU1698997A (en) | 1996-01-16 | 1997-08-11 | Merck & Co., Inc. | Tocolytic oxytocin receptor antagonists |
| US6297274B1 (en) * | 1996-04-10 | 2001-10-02 | Warner-Lambert Company | Nonpeptide endothelin antagonists with increased water solubility |
| DE19617864A1 (de) * | 1996-04-23 | 1997-10-30 | Schering Ag | Neue chirale Phenyldihydrofuranone |
| US6417393B1 (en) | 1996-05-24 | 2002-07-09 | Neurosearch A/S | Phenyl derivatives containing an acidic group, their preparation and their use as chloride channel blockers |
| JPH1087489A (ja) | 1996-09-13 | 1998-04-07 | Sankyo Co Ltd | Ａｈｐｂａ構造含有ジペプチド化合物を有効成分とする医薬 |
| US20020064847A1 (en) | 1996-10-22 | 2002-05-30 | Daicel Chemical Industries, Ltd. | Novel secondary alcohol dehydrogenase, process for preparing said enzyme, and process for preparing alcohols and ketones using said enzyme |
| AU732335B2 (en) | 1997-09-09 | 2001-04-12 | Merck & Co., Inc. | 3-(iodophenoxymethyl) carbapenem antibacterials |
| ATE314347T1 (de) | 1997-09-30 | 2006-01-15 | Daiichi Seiyaku Co | Sulfonylderivate |
| US6255498B1 (en) * | 1998-10-16 | 2001-07-03 | Millennium Pharmaceuticals, Inc. | Method for synthesizing diaryl-substituted heterocyclic compounds, including tetrahydrofurans |
| GB9914371D0 (en) | 1999-06-18 | 1999-08-18 | Smithkline Beecham Plc | Novel compounds |
| CZ302982B6 (cs) | 2000-06-28 | 2012-02-01 | Amgen Inc. | 3-Chinolinylfenylsulfonamidová sloucenina, tato sloucenina pro použití jako lécivo a použití této slouceniny pri výrobe léciva |
| AR031126A1 (es) | 2000-08-29 | 2003-09-10 | Abbott Lab | Acidos amino(oxo)aceticos inhibidores de la proteina tirosina fosfatasa |
| AR035216A1 (es) | 2000-12-01 | 2004-05-05 | Astrazeneca Ab | Derivados de acido mandelico ,derivados farmaceuticamente aceptables, uso de estos derivados para la fabricacion de medicamentos, metodos de tratamiento ,procesos para la preparacion de estos derivados, y compuestos intermediarios |
| CZ20033394A3 (cs) | 2001-06-12 | 2005-03-16 | Wellstat Therapeutics Corporation | Sloučeniny pro léčení metabolických poruch a způsob jejich přípravy |
| US20040092529A1 (en) * | 2002-10-30 | 2004-05-13 | Pfizer Inc | Methods of using piperazine derivatives |
| JP2006507303A (ja) | 2002-11-01 | 2006-03-02 | ウェルスタット セラピューティクス コーポレイション | 代謝障害の処置のための化合物 |
| MXPA05008600A (es) | 2003-02-13 | 2005-11-04 | Wellstat Therapeutics Corp | Compuestos para el tratamiento de desordenes metabolicos. |
| SI1633340T1 (sl) | 2003-04-15 | 2011-02-28 | Wellstat Therapeutics Corp | Spojine za zdravljenje metaboličnih motenj |
| EP1618086B1 (en) | 2003-04-22 | 2009-12-02 | Wellstat Therapeutics Corporation | Compounds for the treatment of metabolic disorders |
| US7442796B2 (en) | 2003-04-30 | 2008-10-28 | Wellstat Therapeutics Corporation | Compounds for the treatment of metabolic disorders |
| MXPA06001963A (es) | 2003-08-20 | 2006-05-31 | Wellstat Therapeutics Corp | Compuestos para el tratamiento de trastornos metabolicos. |
-
2007
- 2007-01-22 US US12/160,857 patent/US7915429B2/en active Active
- 2007-01-22 CN CNA2007800035189A patent/CN101374414A/zh active Pending
- 2007-01-22 EP EP07717339A patent/EP1976510A4/en not_active Withdrawn
- 2007-01-22 NZ NZ569728A patent/NZ569728A/en not_active IP Right Cessation
- 2007-01-22 KR KR1020087018413A patent/KR20080089453A/ko not_active Ceased
- 2007-01-22 CA CA002637373A patent/CA2637373A1/en not_active Abandoned
- 2007-01-22 JP JP2008552535A patent/JP2009524686A/ja active Pending
- 2007-01-22 WO PCT/US2007/060830 patent/WO2007087504A2/en not_active Ceased
- 2007-01-22 AU AU2007208125A patent/AU2007208125B2/en not_active Ceased
-
2008
- 2008-06-26 ZA ZA200805595A patent/ZA200805595B/xx unknown
- 2008-07-16 IL IL192851A patent/IL192851A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009531280A5 (enExample) | ||
| JP2009528375A5 (enExample) | ||
| JP2009528275A5 (enExample) | ||
| JP2009537559A5 (enExample) | ||
| CA2513092A1 (en) | Compounds for the treatment of metabolic disorders | |
| CA2521621A1 (en) | Compounds for the treatment of metabolic disorders | |
| CA2522738A1 (en) | Compounds for the treatment of metabolic disorders | |
| JP2006524252A5 (enExample) | ||
| CA2521589A1 (en) | Compounds for the treatment of metabolic disorders | |
| JP6238460B2 (ja) | 脂質異常症治療剤 | |
| AU2007235145B2 (en) | Combination treatment of metabolic disorders | |
| RU2010141823A (ru) | Соединения и способ снижения мочевой кислоты | |
| JP2010501010A5 (enExample) | ||
| JP2008513499A5 (enExample) | ||
| RU2008123000A (ru) | Соединения для лечения метаболических нарушений | |
| JP2007523155A5 (enExample) | ||
| JP2005526696A5 (enExample) | ||
| RU2004105956A (ru) | Новые производные винилкарбоновых кислот и их применение в качестве антидиабетических средств и т.п. | |
| JP2009524686A5 (enExample) | ||
| CA2502297A1 (en) | Compounds for the treatment of metabolic disorders | |
| RU2006108572A (ru) | Соединения для лечения метаболических нарушений | |
| CN1159305C (zh) | 新的2-(n-氰基亚氨基)噻唑烷-4-酮衍生物 | |
| JP2021001221A (ja) | 精神障害の治療における使用のためのイロペリドン代謝物 | |
| JP2009539877A5 (enExample) | ||
| TW201306830A (zh) | 用於治療糖尿病及新陳代謝疾病的組合物及其製備方法 |